INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 135 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 20,067,883 | $8,960,310 | 0.00% |
| JPMORGAN CHASE & CO | 3,018,482 | $1,347,753 | 0.00% |
| Schonfeld Strategic Advisors LLC | 107,687 | $48,080 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 178,194 | $79,564 | 0.00% |
| Allworth Financial LP | 375 | $168 | 0.00% |
| IFP Advisors, Inc | 1,504 | $3,833 | 0.00% |
| Kistler-Tiffany Companies, LLC | 365 | $163 | 0.00% |
| Man Group plc | 59,396 | $26,520 | 0.00% |
| Sunbelt Securities, Inc. | 250 | $112 | 0.00% |
| Squarepoint Ops LLC | 20,802 | $9,288 | 0.00% |
| ROYAL BANK OF CANADA | 14,583 | $7,000 | 0.00% |
| ICA Group Wealth Management, LLC | 25 | $11 | 0.00% |
| Cetera Advisor Networks LLC | 11,607 | $5,183 | 0.00% |
| Horan Securities, Inc. | 1,702 | $760 | 0.00% |
| THRIVENT FINANCIAL FOR LUTHERANS | 20,000 | $9 | 0.00% |
| FMR LLC | 25,310 | $11,301 | 0.00% |
| Tradewinds Capital Management, LLC | 6 | $3 | 0.00% |
| US BANCORP \DE\ | 2,550 | $1,139 | 0.00% |
| Creative Planning | 17,958 | $8,018 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 61,331 | $27,384 | 0.00% |
External links
This page lists INOVIO PHARMACEUTICALS INC's shareholders in Q2 2023. To view INOVIO PHARMACEUTICALS INC's shareholder history, click here.